Patent details
EP3064206 Title: TREATMENT OF HUNTINGTON'S DISEASE USING LAQUINIMOD
Basic Information
- Publication number:
- EP3064206
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP161605225
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF HUNTINGTON'S DISEASE USING LAQUINIMOD
- French Title of Invention:
- TRAITEMENT DE LA MALADIE DE HUNTINGTON UTILISANT DU LAQUINIMOD
- German Title of Invention:
- BEHANDLUNG DER HUNTINGTON-KRANKHEIT MIT LAQUINIMOD
- SPC Number:
Dates
- Filing date:
- 09/08/2010
- Grant date:
- 20/03/2019
- EP Publication Date:
- 07/09/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/03/2019
- EP B1 Publication Date:
- 20/03/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/08/2019
- Expiration date:
- 09/08/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/03/2019
- Name:
- Active Biotech AB
- Address:
- Box 724, 220 07 Lund, Sweden (SE)
Inventor
- Name:
- HAYARDENY, Liat
- Address:
- Israel (IL)
Priority
- Priority Number:
- 273920 P
- Priority Date:
- 10/08/2009
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/138; A61K 31/428; A61K 31/4704; A61P 25/00; A61P 25/16; A61P 25/18; A61P 25/22; A61P 25/24; A61P 25/28;
Publication
European Patent Bulletin
- Issue number:
- 201912
- Publication date:
- 20/03/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|